Skip to content

HCA Healthcare, Inc.

HCA Healthcare

HCA · NYSE

Healthcare

Catalog as of September 15, 2026. Not a live market feed.

Fiscal Year
2025
Revenue
$75.6B
Assets
$60.7B
SEC filing
DEF 14A
Filed
March 13, 2026

Executive Compensation

Compensation reported for HCA Healthcare’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.

Samuel N. Hazen

Chief Executive Officer

$26.5M

Reported total · FY2025 · SCT Total as filed

Source: DEF 14A Summary Compensation Table, filed March 13, 2026.

Salary
$1.6M
Stock Awards
$8.5M
Option Awards
$8.5M
Incentives
$5.4M
Other
$2.5M

Historical Compensation

Samuel N. Hazen total compensation, fiscal years 2023–2025.

Year-by-year total compensation
Fiscal YearSalaryTotal Compensation
2025$1,577,815$26,456,606
2024$1,539,947$23,799,137
2023$1,512,222$21,315,984

Named Executive Officers

Source information

Company
HCA Healthcare, Inc.
Ticker
HCA · NYSE
Filing type
DEF 14A
Fiscal year
2025
Filing date
March 13, 2026
SEC accession number
0001193125-26-106142

Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing

Related Companies